Impact of Semaglutide on Tobacco Use and Related Health Behaviors (NCT06986993)
Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity
🩺 Plain-English Summary (8th-Grade Level)
This pilot randomized trial will assess the impact of 12 weeks of semaglutide administration (vs placebo) on changes in: (i) tobacco use and related factors (nicotine craving, withdrawal, motivation to quit, etc.) and (ii) biological biomarkers of health (e.g., epigenetics, glucose variability via continuous glucose monitoring \[CGM\], etc.) in adult smokers with obesity (n = 40). We will integrate molecular biology procedures (e.g., epigenetics) to maximize internal validity with real-world smartphone-based ecological momentary assessment (EMA) surveys to maximize external validity
Who can join: Review the eligibility criteria below.
Location: Health Promotion Research Center — Oklahoma City, Oklahoma
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Health Promotion Research Center — Oklahoma City, Oklahoma
📞 Contact the Study Coordinator
Phone: (405) 271-1903
Email: heal-lab@ouhsc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Tobacco Use
- CONNECT Cancer Survivors With Tobacco Treatment — St Louis, Missouri
- Salvation Army Tobacco Quit Line Referral Implementation Trial — Madison, Wisconsin
- Comparing an Opt-out to an opt-in Approach for Smoking Cessation in VA Primary Care Clinics — New York, New York
- Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures — Minneapolis, Minnesota
- Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation — Loma Linda, California
- Oral Cannabidiol for Tobacco Cessation — Baltimore, Maryland
Explore by condition: All Tobacco Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.